Clinical Trial Update: Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease [NA]

View source ↗

Summary

Terminated clinical trial evaluating haploidentical hematopoietic stem cell transplantation for severe sickle cell disease, with results posted on 2024-12-04. S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Snippet

Sponsor: University of Chicago | Conditions: Sickle Cell Disease | NA | Status: TERMINATED | Results posted: 2024-12-04